Allianz Asset Management GmbH lessened its stake in shares of HealthSouth Corp (NYSE:HLS) by 6.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 912,586 shares of the company’s stock after selling 67,719 shares during the quarter. Allianz Asset Management GmbH owned 0.93% of HealthSouth worth $42,299,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Epoch Investment Partners Inc. lifted its stake in shares of HealthSouth by 0.4% during the third quarter. Epoch Investment Partners Inc. now owns 736,376 shares of the company’s stock worth $34,131,000 after purchasing an additional 2,680 shares in the last quarter. OxFORD Asset Management LLP increased its position in shares of HealthSouth by 74.5% during the third quarter. OxFORD Asset Management LLP now owns 13,594 shares of the company’s stock worth $632,000 after acquiring an additional 5,804 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of HealthSouth by 19.9% during the third quarter. Dimensional Fund Advisors LP now owns 951,593 shares of the company’s stock worth $44,106,000 after acquiring an additional 157,790 shares during the last quarter. Brown Advisory Inc. increased its position in shares of HealthSouth by 13.8% during the third quarter. Brown Advisory Inc. now owns 11,753 shares of the company’s stock worth $545,000 after acquiring an additional 1,423 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its position in shares of HealthSouth by 16.9% during the third quarter. Schwab Charles Investment Management Inc. now owns 785,074 shares of the company’s stock worth $36,389,000 after acquiring an additional 113,770 shares during the last quarter. Institutional investors own 93.37% of the company’s stock.
Shares of HealthSouth Corp (NYSE HLS) traded up $0.28 during mid-day trading on Friday, reaching $49.36. The company’s stock had a trading volume of 550,200 shares, compared to its average volume of 903,672. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34. HealthSouth Corp has a 12 month low of $38.24 and a 12 month high of $50.41. The firm has a market capitalization of $4,850.00, a P/E ratio of 17.59, a P/E/G ratio of 1.80 and a beta of 0.55.
HealthSouth (NYSE:HLS) last issued its earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. The company had revenue of $995.60 million during the quarter, compared to the consensus estimate of $985.75 million. During the same period in the previous year, the firm posted $0.65 earnings per share. HealthSouth’s quarterly revenue was up 7.4% compared to the same quarter last year. analysts anticipate that HealthSouth Corp will post 2.72 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Tuesday, January 2nd will be paid a $0.25 dividend. The ex-dividend date is Friday, December 29th. This represents a $1.00 dividend on an annualized basis and a yield of 2.03%. HealthSouth’s payout ratio is currently 36.50%.
HLS has been the topic of a number of analyst reports. Royal Bank Of Canada reaffirmed a “buy” rating on shares of HealthSouth in a research report on Wednesday, November 15th. ValuEngine lowered HealthSouth from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Mizuho raised HealthSouth from a “neutral” rating to a “buy” rating and set a $55.00 price objective for the company in a report on Thursday, November 2nd. Stephens started coverage on HealthSouth in a report on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price objective for the company. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $50.00 price objective on shares of HealthSouth in a report on Sunday, September 17th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the stock. HealthSouth currently has a consensus rating of “Hold” and an average price target of $51.75.
In related news, Director Yvonne M. Curl bought 1,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was bought at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the completion of the purchase, the director now directly owns 64,144 shares in the company, valued at approximately $2,947,416.80. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.60% of the company’s stock.
HealthSouth Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).
Receive News & Ratings for HealthSouth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp and related companies with MarketBeat.com's FREE daily email newsletter.